Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial (Q27852787)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial |
scientific article |
Statements
Caicun Zhou
Cheng-Ping Hu
Jifeng Feng
Shun Lu
Yunchao Huang
Wei Li
Mei Hou
Jian Hua Shi
Kye Young Lee
Chong-Rui Xu
Dan Massey
Miyoung Kim
Yang Shi
Sarayut L Geater
February 2014
0 references
Identifiers
2 references
2 references